FCR or FR – which regimen is better for treating CLL?
Promising CLL & FL data from ICML 2017: BGB-3111 and obinituzumab
Why use model systems for multiple myeloma research?
Enrique Ocio et al.
The importance of collaboration across fields and institutions
HARMONY and CLL: the future of research and databases